EMEA-002875-PIP01-20
Key facts
| Active substance |
Allogeneic skin-derived ATP-binding cassette, sub-family B, member 5 (ABCB5)-positive mesenchymal stem cells (allo-APZ2-EB)
|
| Therapeutic area |
Dermatology
|
| Decision number |
P/0247/2021
|
| PIP number |
EMEA-002875-PIP01-20
|
| Pharmaceutical form(s) |
Suspension for injection
|
| Condition(s) / indication(s) |
Treatment of epidermolysis bullosa
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
RHEACELL GmbH & Co. KG
Tel: +49 6221718330 |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|